10 studies found for:    McCune-Albright syndrome, NIH
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention: Drug: Fosamax (Alendronate)
2 Completed Bone Marrow Injection to Replace Diseased Bone in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention:
3 Completed Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Letrozole
4 Recruiting Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: McCune Albright Syndrome
Intervention:
5 Completed A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia
Intervention: Drug: Pegvisomant
6 Completed Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention:
7 Completed Diagnosis and Natural History Study of Patients With Neurological Conditions
Conditions: Alzheimer's Disease;   Dementia;   Movement Disorder;   Multiple System Atrophy;   Parkinson's Disease
Intervention:
8 Recruiting Evaluation of Primary Chronic Autonomic Failure
Condition: Autonomic Nervous System Diseases
Intervention:
9 Terminated
Has Results
Augmenting Effects of L-DOPS With Carbidopa and Entacapone
Conditions: Parkinson Disease;   Multiple System Atrophy;   Autonomic Nervous System Diseases
Interventions: Drug: Droxidopa;   Drug: Carbidopa;   Drug: Entacapone
10 Completed
Has Results
A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa
Conditions: Symptomatic Neurogenic Orthostatic Hypotension (NOH);   Non-diabetic Neuropathy;   Primary Autonomic Failure;   Dopamine Beta Hydroxylase Deficiency
Interventions: Drug: Placebo;   Drug: Droxidopa

Indicates status has not been verified in more than two years